Search results
Prudential PLC Cuts Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 22 hours agoPrudential PLC decreased its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.4% during the 4th quarter, according to the company in its most recent 13F ...
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
Zacks via Yahoo Finance· 16 hours agoFDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of...
FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 8 hours agoEli Lilly stock gained 1.8% during the regular session, closing at 865 just after the final vote...
Biogen Inc. (NASDAQ:BIIB) Stock Position Trimmed by Stephens Inc. AR
ETF DAILY NEWS· 2 days agoStephens Inc. AR cut its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent filing with the Securities ...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 10 hours agoThe FDA typically follows the recommendations of its advisory panels but is not required to do so....
RBC maintains Biogen Outperform stock rating, awaits Leqembi sales acceleration By Investing.com
Investing.com· 6 days agoOn Wednesday, RBC Capital expressed continued confidence in Biogen (NASDAQ:BIIB), maintaining an...
...Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and...
Benzinga· 1 day agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen
Biogen stock favored at RBC as Lilly awaits Alzheimer’s drug
Seeking Alpha· 6 days agoRBC Capital Markets maintains a bullish view on Biogen (BIIB) despite Eli Lilly's (LLY) upcoming FDA...
Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class...
Morningstar· 6 days agoNEW YORK, June 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB). Shareholders who purchased shares of BIIB during the class period listed are encouraged
Here's Why Biogen Inc. (BIIB) is a Strong Momentum Stock
Zacks via Yahoo Finance· 5 days agoThis Score can pinpoint good times to build a position in a stock, using factors like one-week price...